We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.26T Turnover 23.45%
1-Year Est. Return 41.03%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+41.03%
3 Year Est. Return
+173.37%
5 Year Est. Return
+166.23%
10 Year Est. Return
+509.07%
AUM
$1.26T
AUM Growth
-$27.4B
Cap. Flow
-$3.98B
Cap. Flow %
-0.32%
Top 10 Hldgs %
26.48%
Holding
15,103
New
1,828
Increased
5,364
Reduced
6,090
Closed
1,713
Avg Time Held Equity + Options
3.9 years
Top 10 Avg Time Held Equity + Options
4.7 years
Top 20 Avg Time Held Equity + Options
5.5 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.6 years
Top 20 Avg Time Held Equity only
3.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.76%
2 Technology 2.14%
3 Communication Services 0.56%
4 Consumer Discretionary 0.56%
5 Healthcare 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FELE icon
11826
PUT
Franklin Electric
FELE
$4.28B
$211K ﹤0.01%
+2,200
New +$225K
2026 Q3
0 quarters
FATE icon
11827
CALL
Fate Therapeutics
FATE
$139M
$211K ﹤0.01%
89,000
+27,200
+44% +$70.3K
2026 Q1
2 quarters
YEXT icon
11828
CALL
Yext
YEXT
$763M
$211K ﹤0.01%
32,600
+11,800
+57% +$69.7K
2019 Q1
30 quarters
PAR icon
11829
PAR Technology
PAR
$964M
$211K ﹤0.01%
15,328
-18,000
-54% -$311K
2022 Q1
18 quarters
RBCAA icon
11830
CALL
Republic Bancorp
RBCAA
$1.77B
$211K ﹤0.01%
+2,300
New +$218K
2026 Q3
0 quarters
GANX icon
11831
CALL
Gain Therapeutics
GANX
$41.9M
$211K ﹤0.01%
121,900
+93,000
+322% +$170K
2025 Q4
3 quarters
SAA icon
11832
ProShares Ulta SmallCap600
SAA
$25.5M
$211K ﹤0.01%
6,686
-1,754
-21% -$62.8K
2026 Q2
1 quarter
HUMA icon
11833
CALL
Humacyte
HUMA
$150M
$211K ﹤0.01%
404,900
-88,100
-18% -$56.4K
2024 Q2
9 quarters
REZI icon
11834
CALL
Resideo Technologies
REZI
$3.32B
$211K ﹤0.01%
11,600
+3,500
+43% +$88.9K
2026 Q2
1 quarter
HQL icon
11835
abrdn Life Sciences Investors
HQL
$542M
$210K ﹤0.01%
+11,246
New +$227K
2026 Q3
0 quarters
SVIA icon
11836
PUT
Silvia Inc
SVIA
$185M
$210K ﹤0.01%
54,200
-390,300
-88% -$915K
2025 Q3
4 quarters
COFS icon
11837
Choiceone Financial
COFS
$548M
$210K ﹤0.01%
+6,506
New +$219K
2026 Q3
0 quarters
OKLL icon
11838
Defiance Daily Target 2x Long OKLO ETF
OKLL
$178M
$210K ﹤0.01%
21,986
-4,357
-17% -$62.5K
2026 Q1
2 quarters
DERM icon
11839
Journey Medical
DERM
$104M
$210K ﹤0.01%
30,724
+10,723
+54% +$74.7K
2025 Q4
3 quarters
FPI icon
11840
Farmland Partners
FPI
$377M
$210K ﹤0.01%
18,512
-10,011
-35% -$101K
2025 Q4
3 quarters
TDAY icon
11841
USA Today
TDAY
$1.05B
$210K ﹤0.01%
33,393
+10,623
+47% +$78.2K
2021 Q3
20 quarters
IGLB icon
11842
PUT
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.74B
$210K ﹤0.01%
+4,600
New +$221K
2026 Q3
0 quarters
MCRB icon
11843
Seres Therapeutics
MCRB
$14.4M
$210K ﹤0.01%
62,692
+4,364
+7% +$22K
2025 Q4
3 quarters
USG icon
11844
DELISTED
USCF Gold Strategy Plus Income Fund
USG
$210K ﹤0.01%
6,627
-1,065
-14% -$35.3K
2026 Q2
1 quarter
RTACU icon
11845
Renatus Tactical Acquisition Corp I Unit
RTACU
$185M
$210K ﹤0.01%
19,462
+1,658
+9% +$17.9K
2026 Q1
2 quarters
IINC
11846
Alki Consolidated Income ETF
IINC
$22.9M
$210K ﹤0.01%
+8,451
New +$218K
2026 Q3
0 quarters
KOP icon
11847
CALL
Koppers
KOP
$568M
$210K ﹤0.01%
4,600
-13,100
-74% -$622K
2026 Q1
2 quarters
ETEC icon
11848
iShares Breakthrough Environmental Solutions ETF
ETEC
$3.44M
$210K ﹤0.01%
8,633
+1,143
+15% +$30.2K
2026 Q2
1 quarter
CBTL icon
11849
Calamos Laddered Bitcoin 80 Series Structured Alt Protection ETF
CBTL
$3.42M
$210K ﹤0.01%
10,559
-142,453
-93% -$2.63M
2026 Q1
2 quarters
JFLI icon
11850
JPMorgan Flexible Income ETF
JFLI
$45.7M
$210K ﹤0.01%
+3,954
New +$212K
2026 Q3
0 quarters

Similar funds

Jeff Yass's Q3 2026 Portfolio in Review

As of Q3 2026, Jeff Yass held 15,103 positions worth $1.26T, down 2.1% from $1.28T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass's Q3 2026 filing shows 1,828 new, 5,364 increased, 6,090 reduced and 1,713 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M. The largest sale was Microsoft, an estimated $2.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q3 2026 buy was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $4.73B increase.
  • Jeff Yass's biggest Q3 2026 reduction was Microsoft, cutting an estimated $2.88B.
  • Jeff Yass fully exited Capital Group Growth ETF in Q3 2026, selling an estimated $279M.
  • Jeff Yass's ten largest holdings make up 26% of its $1.26T portfolio in Q3 2026.
  • Jeff Yass opened 1,828 new positions and closed 1,713 in Q3 2026.
  • Jeff Yass's portfolio value fell 2.1% quarter-over-quarter to $1.26T.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.